Sinopharm Tech Holdings Limited (HKG:8156)

Sinopharm Tech Holdings Ratios and Metrics

Market cap in millions HKD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 10, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	174	117	17	64	545	1,189
Market Cap Growth	161.90%	571.79%	-72.86%	-88.19%	-54.21%	44.37%
Enterprise Value	320	263	13	99	705	1,348
Last Close Price	0.28	0.18	0.10	0.35	3.00	6.75
PS Ratio	2.85	1.91	0.42	1.50	13.29	15.28
PB Ratio	-4.75	-3.19	-0.08	-0.36	-3.14	-8.46
P/FCF Ratio	-	-	-	13.58	-	-
P/OCF Ratio	-	-	-	13.58	-	-
EV/Sales Ratio	5.23	4.30	0.31	2.31	17.21	17.32
EV/FCF Ratio	-	-	-	20.93	-	-
Debt / Equity Ratio	-0.90	-0.90	-0.36	-0.29	-0.31	-1.15
Debt / FCF Ratio	-	-	-	11.20	-	-
Asset Turnover	1.27	1.27	1.06	0.78	0.39	0.48
Inventory Turnover	5.53	5.53	16.51	33.85	12.86	9.60
Quick Ratio	0.49	0.49	0.13	0.12	0.18	0.13
Current Ratio	0.72	0.72	0.15	0.13	0.19	0.18
Return on Assets (ROA)	-8.88%	-8.88%	-16.68%	-17.12%	-43.83%	-21.54%
Return on Invested Capital (ROIC)	-	-	-	-	-	-131.54%
Return on Capital Employed (ROCE)	41.10%	41.10%	5.10%	8.40%	43.00%	40.80%
Earnings Yield	-0.50%	-0.74%	-112.88%	-16.54%	-16.16%	-8.94%
FCF Yield	-	-4.86%	-72.09%	7.36%	-6.77%	-1.37%
Buyback Yield / Dilution	-153.03%	-153.03%	-0.45%	-1.66%	-4.59%	-4.39%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.